Remifentanil: A novel, short-acting, μ-opioid

Anesthesia and Analgesia

Volumn 83, Issue 3, 1996, Pages 646-651

  Bürkle, Hartmut ^a   Dunbar, Stuart ^b   Van Aken, Hugo ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; FENTANYL; GLYCOPYRRONIUM BROMIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; HYPNOTIC AGENT; ISOFLURANE; MU OPIATE RECEPTOR; NALOXONE; NITROUS OXIDE; PROPOFOL; REMIFENTANIL; SUFENTANIL; THIOPENTAL;

ANESTHESIA; ASSISTED VENTILATION; BOLUS INJECTION; DRUG HALF LIFE; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; HEMODYNAMICS; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; POSTOPERATIVE ANALGESIA; PRIORITY JOURNAL; REVIEW; SEDATION;

EID: 0029795890     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199609000-00038     Document Type: Review

References (52)

1. Feldman PL, James MK, Brackeen MF, et al. Design, synthesis, and pharmacological evaluation of ultrashort- to long-acting opioid analgesics. J Med Chem 1991;34:2202-8.
2. Chen J, Mestek A, Liu J, et al. Molecular cloning and functional expression of a μ-opioid receptor from the rat brain. Mol Pharm 1993;44:8-12.
3. Thompson R, Mansour A, Akil H, Watson S. Cloning and pharmacological characterization of a rat μ-opioid receptor. Neuron 1993;11:903-13.
4. Reisine T, Bell GI. Molecular biology of opioid receptors. Trends Neurosci 1993;16:506-10.
5. Uhl G, Childers S, Pasternak G. An opiate receptor gene family reunion. Trends Neurosci 1994;17:89-93.
6. Atechson R, Lambert DG. Update on opioid receptors. Br J Anaesth 1994;73:132-4.
7. Yaksh TL. The post injury state. Curr Opin Neurol Neurosurg 1993;6:250-6.
8. James MK, Feldman PL, Schuster SV, et al. Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues. J Pharmacol Exp Ther 1991;259:712-8.
9. Amin HM, Sopchak AM, Esposito BF, et al. Naloxone-induced and spontaneous reversal of depressed ventilatory responses to hypoxia during and after continuous infusion of remifentanil or alfentanil. J Pharmacol Exp Ther 1995;274:34-9.
10. Stiller RL, Davis PJ, McGowan FX, et al. In vitro metabolism of remifentanil: the effects of pseudocholinesterase deficiency [abstract]. Anesthesiology 1995;83:A381.
11. Selinger K, Nation RL, Smith G A. Enzymatic and chemical hydrolysis of remifentanil [abstract]. Anesthesiology 1995;83:A385.
12. Glass PS, Hardman D, Kamiyama Y, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). Anesth Analg 1993;77:1031-40.
13. Marton JP, Hardman HD, Kamiyama Y, et al. Analgesic efficacy of single escalating doses of GI 87084B administered to healthy adult male volunteers [abstract]. Anesthesiology 1991;75:A378.
14. Buerkle H, Yaksh TL. Comparison of the spinal actions of the μ-opioid remifentanil with alfentanil and morphine in the rat. Anesthesiology 1996;84:96-102.
15. Buerkle H, Yaksh TL. Studies on continuous intrathecal administration of short lasting μ-opioids, remifentanil and alfentanil, in the rat. Anesthesiology 1996;84:926-35.
16. Glass PS. Remifentanil: a new opioid. J Clin Anesth 1995;7:558-63.
17. Egan TD, Lemmens HJ, Fiset P, et al. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology 1993;79:881-92.
18. Westmoreland CL, Hoke JF, Sebel PS, et al. Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology 1993;79:893-903.
19. Hughes MA, Glass PS, Jacobs JR. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 1992;76:334-41.
20. Kapila A, Muir KT, Herman DJ, et al. Measured context sensitive half times of remifentanil and alfentanil. Anesthesiology 1995;83:968-75.
21. Dershwitz M, Randel GI, Rosow CE, et al. Initial clinical experience with remifentanil, a new opioid metabolized by esterases. Anesth Analg 1995;81:619-23.
22. Joshi P, Jahveri R, Baumann V, et al. Comparative trial of remifentanil and alfentanil for anesthesia induction [abstract]. Anesthesiology 1993;79:A379.
23. Kovac A, Azad S, Batenhorst R, et al. Remifentanil versus alfentanil balanced anesthesia for total abdominal hysterectomy [abstract]. Anesthesiology 1995;83:A383.
24. Philip BK, Scuderi PB, Chung F, et al. Comparison of remifentanil/propofol to alfentanil/propofol for laparoscopic outpatient surgery [abstract]. Anesthesiology 1995;83:A3.
25. Davis PJ, Ross A, Stiller RL, et al. Pharmacokinetics of remifentanil in anesthetized children 2-12 years of age [abstract]. Anesth Analg 1995;80(Suppl):S93.
26. Hoffman WE, Cunningham F, James MK, et al. Effects of remifentanil, a new short-acting opioid, on cerebral blood flow, brain electrical activity, and intracranial pressure in dogs anesthetized with isoflurane and nitrous oxide. Anesthesiology 1993;79:107-13.
27. Baker KZ, Ostapkovich N, Jackson T, et al. Cerebral blood flow reactivity is intact during remifentanil/N2O anesthesia [abstract]. Anesth Analg 1995;80(Suppl):S27.
28. Hindman B, Warner D, Todd M, et al. ICP and CPP effects of remifentanil and alfentanil [abstract]. J Neurosurg Anesth 1994;6:304.
29. Egan TD, Minto C, Lemmens HJM, et al. Remifentanil versus alfentanil: comparative pharmacodynamics. Comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiology 1996;84:821-33.
30. Ostapkovich ND, Baker KZ, Young WL. Characterization of EEC during remifentanil/N2O anesthesia in neurosurgical patients [abstract]. Anesthesiology 1995;83:A193.
31. Moore K, Howie MD, Jopling MW, et al. EEG characteristics during continuous infusion of remifentanil for CABG surgery [abstract]. Anesthesiology 1995;83:A377.
32. Smith I, Avramov M, White PF. Remifentanil versus propofol for monitored anesthesia care-effects on ventilation [abstract]. Anesthesiology 1995;83:A4.
33. Pitts MC, Palmore MM, Salmenpera MD, et al. Hemodynamic effects of intravenous GI 87084B (GI) in patients undergoing elective surgery [abstract]. Anesthesiology 1992;77:A101.
34. Sebel PS, Hoke JF, Westmoreland C, et al. Histamine concentrations and hemodynamic responses after remifentanil. Anesth Analg 1995;80:990-3.
35. Bacon R, Chandrasekan V, Haigh A, et al. Early extubation after open-heart surgery with total intravenous anaesthetic technique. Lancet 1995;345:133-4.
36. Duthie DJR, Stevens WM, Doyle AR, Baddoo MHK. Remifentanil and coronary artery surgery. Lancet 1995;345:649-50.
37. Minto CF, Schnider TW, Cohane CN, et al. The hemodynamic effects of remifentanil in volunteers over 70 years [abstract]. Anesthesiology 1994;81:A11.
38. Michelsen LG, Hoke JF, Hug CC, et al. Pharmacokinetics of remifentanil in cardiac surgical patients [abstract]. Anesthesiology 1995;83:A379.
39. Royston D. Remifentanil in cardiac surgery. Bur J Anaesthesiol Suppl 1995;10:77-9.
40. Desmonts JM, Aitkenhead AR, Camu F, et al. Comparison of remifentanil and propofol as adjunct therapy during regional anesthesia [abstract]. Anesthesiology 1995;83:A857.
41. Munday I, Ward PM, Sorooshian S, et al. Interaction between remifentanil and isoflurane in spontaneously breathing patients during ambulatory surgery [abstract]. Anesthesiology 1995;83:A23.
42. Peacock J, Reilly C, Luntely J, et al. Remifentanil in combination with propofol for spontaneous ventilation anaesthesia [abstract]. Anesthesiology 1995;83:A35.
43. Dershwitz M, Hoke JF, Rosow CE, et al. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Anesthesiology 1996;84:812-20.
44. Navapurkar VU, Archer S, Frazer NM, et al. Pharmacokinetics of remifentanil during hepatic transplantation [abstract], Anesthesiology 1995;83:A382.
45. Shlugman D, Dufore S, Dershwitz M, et al. Respiratory effects of remifentanil in subjects with severe renal impairment compared to matched controls [abstract]. Anesthesiology 1994;81:A1417.
46. Monk TG, Batenhorst R, Jamerson B, et al. Comparison of remifentanil and alfentanil concentrations with stress hormone responses during nitrous-narcotic anesthesia [abstract]. Anesthesiology 1995;83:A380.
47. Sung YF, Shilling RD, Beatie CD, et al. Intraocular pressure (IOP) effects of remifentanil (R) (GI87084B) and alfentanil [abstract]. Anesthesiology 1994;81:A35.
48. Hogue C, Camporesi E, Duncalf D, et al. Total intravenous anesthesia with remifentanil and propofol in patients undergoing elective inpatient surgery [abstract]. Anesthesiology 1995;83:A386.
49. Kapila A, Lang E, Glass P, et al. MAC reduction of isoflurane by remifentanil [abstract]. Anesthesiology 1994;81:A378.
50. Me Ewan AI, Smith C, Dyar O, et al. Isoflurane minimum alveolar concentration reduction by fentanyl. Anesthesiology 1993;78:864-9.
51. Westmoreland C, Sebel PS, Groper A, et al. Reduction of isoflurane MAC by fentanyl or alfentanil [abstract]. Anesthesiology 1992;77:A394.
52. Thompson JP, Rowbotham DJ. Remifentanil-an opioid for the 21st century. Br J Anaesth 1996;76:341-3.